Santen stock gets a new FY2026 strategy update

Santen Pharmaceutical Co., Ltd. (ISIN JP3336000009) was last at JPY 1,677 on the Tokyo Stock Exchange on October 7, 2026, while the eye-care company released a new integrated report. According to Santen on October 7, 2026, the report covers the fiscal year ended March 31, 2026, and the FY2025-2029 Medium-Term Management Plan.

Report sets the strategic frame

The report presents Santen as a pharmaceutical company focused exclusively on eye health, with products and services available in more than 60 countries and regions. Its portfolio spans glaucoma, dry eye, infection, allergy, age-related macular degeneration, and myopia, giving the report a broad commercial frame beyond a single product or market.

The timing matters because the publication follows Santen's first-quarter results for the fiscal year ending March 31, 2027. The report therefore adds a strategy reference to the latest operating figures rather than replacing the earnings picture with a new forecast.

Revenue edges higher in Q1

JPX Market Explorer reports that Santen's quarter ended June 30, 2026, produced revenue of JPY 68.96 billion, up 0.3 percent from the year-earlier quarter. Net income reached JPY 7.19 billion, while the reported EBITDA margin improved to 18.61 percent from 17.56 percent.

The comparison is mixed in a useful way: revenue growth was limited to 0.3 percent, but the 1.05 percentage-point EBITDA-margin improvement points to stronger operating conversion in the quarter. Santen's fiscal-year guidance calls for revenue of JPY 311.0 billion, operating profit of JPY 49.5 billion, and net profit of JPY 39.5 billion.

Analysts see upside to JPY 2,377.78

Investing.com lists a Buy consensus from nine analysts, with an average 12-month price target of JPY 2,377.78, a high of JPY 2,800 and a low of JPY 1,900. The average target lies 41.8 percent above the October 7 price of JPY 1,677.

That valuation gap gives investors a concrete counterpoint to the modest revenue increase. It also places the stock 25.6 percent below its 52-week high of JPY 2,254 and JPY 219 below the 52-week low-to-high midpoint of JPY 1,856.

Santen stock stays below its yearly high

Santen stock was last at JPY 1,677 on October 7, 2026, at 3:30 p.m. JST, down 0.39 percent from JPY 1,683.50. The session volume was 944,000 shares, and market capitalization stood at JPY 539.5 billion.

More news and analysis on Santen stock can be found on the Santen stock topic page.